yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26764879-00F8064F-5D93-44F6-BCD1-66AECD581ADB
Q26764879-00F8064F-5D93-44F6-BCD1-66AECD581ADB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26764879-00F8064F-5D93-44F6-BCD1-66AECD581ADB
Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
P2860
Q26764879-00F8064F-5D93-44F6-BCD1-66AECD581ADB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26764879-00F8064F-5D93-44F6-BCD1-66AECD581ADB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46fedc81940791ba697a2a366473de049a4bc059
P2860
Advances and future directions in the targeting of HER2-positive breast cancer: implications for the future.